We are live on ! Find out more
MCM

McKinley Capital Management Portfolio holdings

AUM $571M
1-Year Est. Return 36.44%
This Fund
S&P 500
This Quarter Est. Return
+6.2%
1 Year Est. Return
+36.44%
3 Year Est. Return
+63.3%
5 Year Est. Return
+224.69%
10 Year Est. Return
+867.52%
AUM
$2.07B
AUM Growth
-$4.51M
Cap. Flow
-$44.2M
Cap. Flow %
-2.14%
Top 10 Hldgs %
18.88%
Holding
520
New
183
Increased
97
Reduced
159
Closed
46

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$35.4M
2
AMZN icon
Amazon
AMZN
+$30.3M
3
ZBH icon
Zimmer Biomet
ZBH
+$27.2M
4
JNJ icon
Johnson & Johnson
JNJ
+$26.2M
5
NWL icon
Newell Brands
NWL
+$24.8M

Sector Composition

Rank Sector Weight
1 Healthcare 17.82%
2 Consumer Discretionary 12.88%
3 Industrials 11.98%
4 Technology 11.97%
5 Communication Services 11.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMN icon
76
AMN Healthcare
AMN
$1.19B
$8.34M 0.4%
208,728
+127
+0.1% +$4.7K
IDTI
77
DELISTED
Integrated Device Technology I
IDTI
$8.23M 0.4%
409,088
-152
-0% -$3.22K
CBM
78
DELISTED
Cambrex Corporation
CBM
$8.16M 0.39%
157,811
-41
-0% -$1.96K
HAL icon
79
Halliburton
HAL
$27.1B
$8.07M 0.39%
178,110
-53
-0% -$2.18K
SWBI icon
80
Smith & Wesson
SWBI
$651M
$8.04M 0.39%
385,062
+147,090
+62% +$2.63M
TRU icon
81
TransUnion
TRU
$15.2B
$8.01M 0.39%
+239,389
New +$7.35M
INVX
82
Innovex International
INVX
$2.15B
$7.96M 0.39%
136,310
+32,250
+31% +$1.95M
ABBV icon
83
AbbVie
ABBV
$431B
$7.89M 0.38%
127,482
-1,742
-1% -$106K
ADEA icon
84
Adeia
ADEA
$3.12B
$7.66M 0.37%
945,306
+397,323
+73% +$3.23M
BEAT
85
DELISTED
BioTelemetry, Inc.
BEAT
$7.64M 0.37%
+468,462
New +$6.89M
SANM icon
86
Sanmina
SANM
$11B
$7.46M 0.36%
278,185
+92,878
+50% +$2.32M
DENN
87
DELISTED
Denny's
DENN
$7.46M 0.36%
694,771
-140
-0% -$1.48K
GMED icon
88
Globus Medical
GMED
$11B
$7.42M 0.36%
311,460
-85
-0% -$2.04K
EXPR
89
DELISTED
Express, Inc.
EXPR
$7.42M 0.36%
25,560
+7,203
+39% +$2.42M
XEC
90
DELISTED
CIMAREX ENERGY CO
XEC
$7.39M 0.36%
61,953
+39
+0.1% +$4.37K
NFX
91
DELISTED
Newfield Exploration
NFX
$7.34M 0.36%
+166,240
New +$6.38M
LKQ icon
92
LKQ Corp
LKQ
$6.19B
$7.34M 0.36%
+231,609
New +$7.52M
CRM icon
93
Salesforce
CRM
$153B
$7.28M 0.35%
91,732
+75
+0.1% +$5.89K
LGND icon
94
Ligand Pharmaceuticals
LGND
$6.02B
$7.2M 0.35%
96,752
+54
+0.1% +$4.01K
HCA icon
95
HCA Healthcare
HCA
$88.5B
$7.15M 0.35%
+92,881
New +$7.33M
BRSS
96
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
$7.14M 0.35%
261,575
-47,545
-15% -$1.26M
NVAX icon
97
Novavax
NVAX
$1.27B
$7.13M 0.35%
49,048
+24,466
+100% +$2.8M
USG
98
DELISTED
Usg
USG
$7.1M 0.34%
+263,352
New +$7.19M
FRC
99
DELISTED
First Republic Bank
FRC
$7.09M 0.34%
101,355
+64
+0.1% +$4.43K
XOM icon
100
ExxonMobil
XOM
$642B
$7.05M 0.34%
75,170
-21,060
-22% -$1.86M

Similar funds

McKinley Capital Management's Q2 2016 Portfolio in Review

As of Q2 2016, McKinley Capital Management held 520 positions worth $2.07B, down 0.22% from $2.07B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

McKinley Capital Management's Q2 2016 filing shows 183 new, 97 increased, 159 reduced and 46 closed positions. Its largest new stake was Pfizer: 1,110,190 shares worth $37.1M. The largest sale was Gilead Sciences, an estimated $34.7M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • McKinley Capital Management's largest Q2 2016 buy was Pfizer: 1,110,190 shares worth $37.1M.
  • McKinley Capital Management added most to Amazon in Q2 2016, an estimated $30.3M increase.
  • McKinley Capital Management's biggest Q2 2016 reduction was Gilead Sciences, cutting an estimated $34.7M.
  • McKinley Capital Management fully exited American International in Q2 2016, selling an estimated $28.8M.
  • McKinley Capital Management's ten largest holdings make up 19% of its $2.07B portfolio in Q2 2016.
  • McKinley Capital Management opened 183 new positions and closed 46 in Q2 2016.
  • McKinley Capital Management's portfolio value fell 0.22% quarter-over-quarter to $2.07B.

Based on McKinley Capital Management's 13F filing for Q2 2016, filed 9 Aug 2016.